Kurt Schalper

29PUBLICATIONS
223CO-AUTHORS
Cancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|May 21, 2026
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers.

|Dec 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI).

Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales

|Oct 10, 2025
Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer.

Thazin N Aung, James Monkman, Jonathan Warrell

|Sep 11, 2025
High MGMT expression identifies aggressive colorectal cancer with distinct genomic features and immune evasion properties.

Janie Yue Zhang, Barani Kumar Rajendran, Shruti S Desai

|Jun 25, 2025
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy.

Ryan J Sullivan, Anthony R Cillo, Robert L Ferris

|Feb 27, 2025
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.

Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do

Pageof 5

Frequent Collaborators

8 joint publications

David L Rimm

5 joint publications

Miguel Lopez de Rodas

4 joint publications

Roy S Herbst

3 joint publications

Natalie Vokes